Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer. (Q54318225)
Jump to navigation
Jump to search
scientific article published on 19 December 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer. |
scientific article published on 19 December 2011 |
Statements
Biomarker analysis in a phase III study of pemetrexed-carboplatin versus etoposide-carboplatin in chemonaive patients with extensive-stage small-cell lung cancer. (English)
E F Smit
M A Socinski
B P Mullaney
S P Myrand
G V Scagliotti
M Reck
T Ciuleanu
J von Pawel
N A Karaseva
A Szczesna
D Ohannesian
E Powell
R R Hozak
S Hong
S C Guba
N Thatcher
19 December 2011
23
7
1723-1729